2009 United-4 a Cure Donations / Funding
This year so far, we have collected $105,541.00.
The funding will be disbursed as follows.
Loyola University
Dr. Joseph I. Clark
$40,000.00
Metastatic melanoma carries a poor prognosis. Chemotherapy is only palliative with a brief duration of response. Immunotherapy had striking but limited success in patients with malignant melanoma. This research represents a new frontier in cancer immunotherapy. It aims to develop new strategies that utilize and enhance the effect of interleukin-2 in combating this disease. Interleukin-2 is the only approved immunotherapeutic agent for metastatic melanoma. It’s also a very promising agent because of its ability to induce a durable and complete response.
The University of Chicago
Dr. Eugene A. Choi
$35,000.00
Pancreatic cancer is a disease that is extremely difficult to treat and has a very grim prognosis (survival rate of only 4.6%). Many patient unfortunately often present with locally invasive or metastatic disease. This can prevent curative surgery. The primary objective of this research is to study the mechanism of progression and spread of pancreatic cancer. This research is aimed to explore the role of a specific gene (miRNA let-7) which believe to inhibit cell invasion and tumor metastasis in pancreatic cancer. A greater understanding of this mechanism help better identify patients at risk for metastasis and also point to potential targets for therapy.
Mayo Clinic
$15,000.00
The Mayo Clinic Research Laboratory Information Management System (RLIMS) is a state of the art, expandable database that is helping to bring new therapies to patients by streamlining access to stored tissue samples. Mayo clinic has preserved several million biological specimens over the past century. These samples are a virtual gold mine for all healthcare researchers. By funding this project, Mayo Clinic will be able to save researchers time and energy by adding all its pre-existing pancreatic cancer tissue samples into the RLIMS catalogue
Cancer Research Center of Hawaii
Dr. Haining Yang
$15,541.00
Over the past 50 years the incident of mesothelioma has shown the highest increase compared to any other malignancy. Mesothelioma is one of the most aggressive human cancers. And it is incurable unless is detected in its earlier stages. Early detection is a crucial element in combating this disease. This project will help to identify the gene that makes some people more susceptible to asbestos carcinogenesis and at a high risk of the disease. It is anticipated that the identification of the gene that cause the most devastating cancer epidemics ever reported will represent a major breakthrough in cancer research and its hoped that will lead to the design of novel anticancer drugs that will benefit all cancer patients.
Click here for a
last of past recipients.
Corporate Sponsors
|
